✦ LIBER ✦

Acute profound thrombocytopenia after use of eptifibatide for coronary stenting

✍ Scribed by Emmanuel Salengro; Niall T. Mulvihill; Bruno Farah

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 46 KB
Volume: 58
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.10390

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet glycoprotein IIb/IIIa inhibitio

Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: A 30-day follow-up study

✍ Upendra Kaul; Ripen K. Gupta; Kottaram K. Haridas; Saligrama S. Ramesh; Kamal K. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Acute and late outcome after use of 2.5-

Acute and late outcome after use of 2.5-mm intracoronary stents in small (< 2.5 mm) coronary arteries

✍ Paul Huang; Thomas Levin; Ameer Kabour; Ted Feldman 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

Hemodynamic rounds series II: Coronary h

Hemodynamic rounds series II: Coronary hemodynamics for angioplasty and stenting after myocardial infarction: Use of absolute, relative coronary velocity and fractional flow reserve

✍ Kern, Morton J. ;Puri, Sanjeev ;Craig, W. Randall ;Bach, Richard G. ;Donohue, Th 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 2 views

The application of absolute coronary velocity reserve, relative coronary velocity reserve, and pressure-derived fractional flow reserve of the myocardium may have influence on decision making for angioplasty and stenting in patients after myocardial infarction. This case highlights the use and limit

Feature topic: Clinical use of abciximab

Feature topic: Clinical use of abciximab: Coronary artery stenting for suboptimal PTCA results in acute myocardial infarction in patients treated with abciximab: Early and six-month outcome

✍ Murdock, David K. ;Logemann, Timothy ;Hoffmann, Mark T. ;Olson, Karen J. ;Engelm 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

Emergent percutaneous transluminal coronary angioplasty (PTCA) is an effective treatment for acute myocardial infarction. However, occasionally results of angioplasty are suboptimal due to coronary dissection or elastic recoil, leading to a high chance of recurrent ischemia. Coronary stents are occa

Acute and 6-month clinical and angiograp

Acute and 6-month clinical and angiographic outcome after implantation of the ACS Duet stent for single-vessel coronary artery disease: Final results of the European and U.S. ACS Multi-link Duet Registry

✍ David P. Foley; Dean Kererakes; Jan A.M. te Riele; Naomi Nishimura; Susan Veldho 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

Upendra Kaul, Ripen K. Gupta, Kottaram K

Upendra Kaul, Ripen K. Gupta, Kottaram K. Haridas, Saligrama S. Ramesh, Kamal K. Sethi, Balbir Singh, Rajiv Agarwal, Ram D. Yadave, Tapan Ghose, Rakesh R. Sapra, Rajiv Bajaj, Madhukar Shahi, Ajit Bhagwat, Pramod Kumar, Omen P. Mathews, Pratik K. Soni. Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: A 30-day follow-up study. Cathet Cardiovasc Intervent 2002;57(4):497–503

✍ Upendra Kaul 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB